Skip to content
Open access

Palmitoylation-related lncRNAs link molecular signaling, immune remodeling, and tumor progression in glioma: prognostic modeling and functional validation of LYRM4-AS1

Sep 2026 · Frontiers in Molecular Neuroscience · Vol 19 · 0 citations · 65 references
Medicine

TL;DR

This study identifies a palmitoylation-related lncRNA signature that integrates molecular signaling, immune remodeling, and prognosis in glioma and indicates LYRM4-AS1 acts as a functional driver of glioma progression and may represent a candidate biomarker and therapeutic target at the crossroads of neural tumorigenesis and immune-microenvironmental regulation.

Abstract

Background Glioma is a molecularly heterogeneous tumor of the central nervous system with variable clinical behavior, immune contexture, and therapeutic response. Palmitoylation is a reversible lipid modification that regulates membrane localization, synaptic signaling, inflammatory pathways, and oncogenic signaling; however, the prognostic and functional relevance of palmitoylation-related long non-coding RNAs (PRlncRNAs) in glioma remains incompletely defined. Methods Transcriptomic and clinical data for 429 glioma patients were obtained from TCGA. Thirty palmitoylation-related genes were used to identify PRlncRNAs through co-expression analysis. A prognostic signature was constructed using univariate Cox regression, LASSO-Cox regression, and multivariate Cox regression. The model was evaluated by Kaplan-Meier analysis, ROC curves, time-dependent ROC analysis, Cox regression, C-index analysis, nomogram modeling, calibration curves, and an institutional clinical cohort of 46 paired glioma and adjacent tissues. Functional enrichment, immune deconvolution, tumor microenvironment scoring, TIDE-based immunotherapy prediction, TMB/MSI analysis, and pRRophetic-based drug-sensitivity analysis were performed. U87 and U251 glioma cells, LYRM4-AS1 knockdown, in vitro functional assays, and nude-mouse xenografts were used for biological validation. Results A six-PRlncRNA signature consisting of POLR2J4, LYRM4-AS1, BX640514.2, AL592295.6, AL390755.1, and AC018730.1 stratified glioma patients into high- and low-risk groups with significantly different overall survival. The risk score remained an independent prognostic factor and showed strong predictive performance for 1-, 3-, and 5-year survival. Risk-associated genes were enriched in extracellular matrix organization, leukocyte-mediated immunity, neuroactive ligand-receptor interaction, MAPK signaling, cytokine-receptor interaction, cell-cycle programs, and ECM-receptor interaction. High-risk tumors displayed increased stromal, immune, and ESTIMATE scores, higher expression of multiple immune checkpoint genes, higher TIDE scores, and elevated TMB/MSI levels. Clinical validation confirmed differential expression of the six PRlncRNAs and the prognostic value of the risk score. Functionally, LYRM4-AS1 knockdown inhibited glioma cell proliferation, EdU incorporation, migration, invasion, and colony formation, while suppressing xenograft growth, increasing TUNEL-positive apoptotic cells, and reducing Ki-67, CD31, and MMP9 expression. Conclusion This study identifies a palmitoylation-related lncRNA signature that integrates molecular signaling, immune remodeling, and prognosis in glioma. LYRM4-AS1 acts as a functional driver of glioma progression and may represent a candidate biomarker and therapeutic target at the crossroads of neural tumorigenesis and immune-microenvironmental regulation.

Read PDF

Similar papers

Open access Sep 2026

A palmitoylation-associated three-gene signature predicts prognosis, immune features, and drug sensitivity in gastric cancer: functional validation of CTHRC1

The SERPINE1/CTHRC1/EGR1 signature provides prognostic and immune-stromal information in GC, and the experiments support a tumor-promoting role for CTHRC1, which defines a palmitoylation-associated transcriptional framework but do not establish a palmitoylation-dependent mechanism.

Hong-Mei Sheng, Xue-Jun Li, Chen Zhang et al. · 0 citations
Open access Sep 2026

A palmitoylation-related signature predicts prognosis and immune microenvironment features in diffuse large B-cell lymphoma

The PRS captures prognostic heterogeneity and distinct immune microenvironment features in DLBCL and may provide a useful tool for risk stratification, and CEACAM3 may serve as a potential biomarker and therapeutic target in DLBCL.

Jie Zhang, Xiao-Bing Miao, Hao Yang et al. · 0 citations
Open access Sep 2026

Integrative single-cell and bulk transcriptomics uncovers a lipid metabolism-related lncRNA signature alongside the ELFN1-AS1/LYPLA1 axis driving osteosarcoma progression

The oncogenic ELFN1-AS1/LYPLA1 regulatory cascade is characterized as a potential biomarker and therapeutic target for precision management of osteosarcoma and establishes an LMRL-based for osteosarcoma prognostic stratification that reflects immune, genomic and therapeutic heterogeneity.

Xian-Fu Wei, Zhi-Peng Wang, Qiang Yang et al. · 0 citations
Aug 2026

Multi-omics integration and functional validation identify thrombospondin-1 as a functionally relevant mediator of doramectin-associated inhibition of glioblastoma migration and invasion.

RNA sequencing of DRM-treated versus control rat C6 glioma cells identified 3747 differentially expressed genes, including 1660 upregulated and 2087 downregulated genes, with thrombospondin-1 markedly downregulated after DRM treatment, which may contribute to the anti-invasive effects of DRM.

Hefei Liu, Hong-Sheng Liang, Liwei Wang et al. · 0 citations
Open access Sep 2026

Cross-Cancer Characterization of CAMK2A Reveals Its Favorable Prognostic Association and Neuronal Signature Enrichment in Glioma

Background: Calcium/calmodulin-dependent protein kinase II alpha (CAMK2A) is a neuron-enriched kinase that plays essential roles in synaptic signaling and neuronal differentiation. However, its clinical significance and biological relevance in glioma remain incompletely understood. This study aimed to systematically ch...

Yi-Min Pan, Chang-Wu Wu, Jun Tan et al. · 0 citations
Sep 2026

Bioinformatics Identification and Functional Validation of Mitochondrial Homeostasis-Related Genes in Nasopharyngeal Carcinoma Metastasis.

This study identified four novel mitochondrial homeostasis-associated hub genes involved in NPC metastasis, established a mitochondria-based molecular subtyping scheme, and provided preliminary prognostic biomarkers and potential therapeutic targets for future mechanistic and translational investigations of metastatic...

Zhen Guo, Bin-Sheng He, Dan-Feng Cao · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.